Drug intelligence / Profile preview

dextrose monohydrate + magnesium acetate + potassium acetate + sodium chloride

Development stage
Approved
Lead developer
ICU Medical
Modality
Small Molecules
Administration
Intravenous
01

Overview

**Dextrose monohydrate + magnesium acetate + potassium acetate + sodium chloride** is a fixed-combination intravenous fluid, electrolyte, and nutrient replenisher marketed by ICU Medical as **Normosol-M and 5% Dextrose Injection**. This sterile, nonpyrogenic, hypertonic solution provides 5% dextrose for limited carbohydrate calories together with sodium, chloride, potassium, magnesium, and acetate ions to support routine parenteral maintenance of daily fluid and electrolyte requirements. It contains 5 g dextrose hydrous, 234 mg sodium chloride, 128 mg potassium acetate, and 21 mg anhydrous magnesium acetate per 100 mL, and is administered by intravenous infusion. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=aba60c84-94d9-46d0-bdbb-25e0c4e8cc41))

Brand names
Normosol-M and 5% Dextrose Injection
Other names
Normosol-M and Dextrose

Beyond the preview

Go deeper on dextrose monohydrate + magnesium acetate + potassium acetate + sodium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextrose monohydrate + magnesium acetate + potassium acetate + sodium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call